Join ACC's Prevention of Cardiovascular Disease Member Section this Wednesday, April 9 at 1 p.m. ET for a recap of ACC.25 prevention content and its influence on clinical practice. The webinar will review several key trials and sessions presented during ACC.25. Experts from ACC's Prevention of Cardiovascular Disease Council will discuss the trial findings and how to apply them to clinical practice. Learn more.
Cardiac rehabilitation offers one-on-one supervised exercise regimens and practical advice for heart-healthy eating and stress reduction. Supporting recommendations from the latest guideline on acute coronary syndromes, CardioSmart's latest infographic shares the benefits of participating in a cardiac rehabilitation program, what these programs entail, and where patients can access care. View the infographic.
Understand the role of high-sensitivity c-reactive protein (hs-CRP) as a biomarker in assessing inflammation and cardiovascular disease risk, the importance of screening, and the value of an interprofessional approach to enhance patient outcomes and maintain cardiovascular health with ACC's new online course, Inflammation in Cardiovascular Health: Raising Awareness of the Increasing Role of hs-CRP. The course includes an infographic describing the role of hs-CRP and influencing factors, as well as materials on hs-CRP codes, recommendations, approaches and further research. Be on the lookout for additional activities including podcast episodes, case-based lessons, and more coming soon! Learn more.
Look for additional activities including podcast episodes, case-based lessons and more coming soon! Learn more.
Join Vivek Kulkarni, MD, FACC, on Friday, March 28 from 1-5 p.m. CT, for a pre-conference workshop designed for navigating the world of research and evidence-based guidelines – with special focus on the TAVR-Unload Trial and 2020 ACC/AHA Valve Disease Guideline. Practice applying JACC articles and clinical guidelines to a real-world case, with guidance from expert coaches in the field, including Sandra M. Oliver-McNeil, DNP, ACNP-BC, FACC; Erica Spatz, MD, FACC; and Muthiah Vaduganathan, MD. Register today for ACC.25, taking place March 29-31 in Chicago, and add the JACC Workshop to your registration. Already registered? Login to your attendee dashboard to add the workshop to your registration.
Join ACC's Prevention of Cardiovascular Disease Member Section on Wednesday, April 9 at 1 p.m. ET for a recap of ACC.25 prevention content and its influence on clinical practice. The webinar will review several key trials and sessions presented during ACC.25. Experts from ACC's Prevention of Cardiovascular Disease Council will discuss the trial findings and how to apply them to clinical practice. Learn more.
Join ACC's Prevention of Cardiovascular Disease Member Section at the Prevention Section Happy Hour for networking and opportunities for engagement during ACC.25. The happy hour will take place Saturday, March 29, from 5:30-6:30 p.m. CT at the Marriott Marquis. All ACC members are welcome to join this event and learn more about the section. Register today!
The Cardiovascular Disease Prevention Learning Pathway at ACC.25 will showcase the rapid evolution of preventive cardiology, from breakthrough therapeutics to innovative prevention strategies. During this unforgettable experience, taking place March 29-31 in Chicago, IL, experts will help you master both foundational approaches and cutting-edge developments that are transforming cardiovascular risk reduction. Attend sessions on SGLT2 inhibitors, GLP-1RA, and the intricate relationships between cardiac, kidney, and metabolic disease. Plus, catch a year in review by Erica Sarah Spatz, MD, FACC. Register here.
Time is running out to showcase your expertise! JACC: Case Reports is seeking standout cases that highlight the critical role of multi-modality imaging in the diagnosis or intervention of complex cardiovascular diseases. Submissions are due by Wednesday, Jan. 15 and must feature the use of at least two distinct imaging modalities – such as fluoroscopy and echocardiography, MRI and CT, 3D printing and angiography, or nuclear imaging and angiography. Don't miss this opportunity to share your insights and advance the field. Submit your case today!
JACC: Case Reports is seeking your best cases illustrating the importance of multi-modality imaging guided diagnosis or intervention for complex cardiovascular diseases. Cases must demonstrate at least usage of two different imaging modalities (i.e., fluoroscopy and echocardiography, MRI and CT, 3D print and angiography, nuclear and angiography, etc.) Submissions are due by Jan. 15, 2025. Learn more and submit today!
Get a jump start on ACC.25, taking place March 29-31, 2025, in Chicago, IL, by attending a pre-conference course, Renal Denervation: The Hypertension Care Team Approach, on Friday, March 28. Join expert faculty for an update on contemporary approaches to hypertension management, including live simulation stations with hands-on experience with renal denervation technology. Registration is free but space is limited – register today!
There's still time to join your colleagues at the Valentin Fuster Cardiovascular Symposium, taking place Dec. 6-8 in Washington, DC. Explore sessions on the topic of prevention such as:
Gain insights from world-renowned experts and connect with leaders in cardiovascular care – register today before it's too late!
JACC: Advances is calling for papers for a special focus issue on "Advances in Preventive Cardiology and Cardio-Kidney-Metabolic Disease" reflecting the journal's commitment to advancing preventive medicine in these interrelated conditions. Submissions are due by Dec. 18. Learn more.
Showcase your cutting-edge simulator in the ACC.25 Cardio Sim Creator Competition and pave the way for advancements in simulation-based education.
Join experts from ACC's Prevention of Cardiovascular Disease Section on Wednesday, Dec. 4 at noon ET for a recap of the 2024 American Heart Association (AHA) Scientific Sessions' prevention content and how new findings can be applied to clinical practice.
Join your colleagues at ACC.25, taking place March 29-31, 2025, in Chicago, IL, and get the knowledge you need to transform cardiovascular care for all! You'll have the opportunity to discuss the latest science with top experts, learn how clinical guidelines translate into your daily practice, and build lasting connections with your peers. Register by Nov. 20 to SAVE up to $300 with early bird discounts and get all-inclusive access to ACC.25!
JACC: Advances is calling for papers for a special focus issue on "Advances in Preventive Cardiology and Cardio-Kidney-Metabolic Disease" reflecting the journal's commitment to advancing preventive medicine in these interrelated conditions.
Transform the future of patient care by sharing your late-breaking clinical trial (LBCT) research with the global cardiovascular community at ACC.25, taking place March 29-31, 2025, in Chicago, IL.
The elevation of lipoprotein(a) (Lp[a]) is a common risk factor responsible for considerable cardiovascular morbidity and mortality. Learn about the unique role of Lp(a) as a genetic determinant for ASCVD risk and the importance of testing for Lp(a) levels with a clinician tool – Lp(a) Assessment and Management: A Clinician's Guide. Plus, register for a FREE webinar, "Lp(a): What You Can Do Now – Current Insights and Future Directions in Cardiovascular Health" taking place Thursday, Nov. 7 at 2 p.m. ET, as part of ACC's Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap online course. Register here.
Join ACC's expert faculty on Thursday, Nov. 7 at 2 p.m. ET for a free webinar, "Lp(a): What You Can Do Now – Current Insights and Future Directions in Cardiovascular Health." As part of ACC's online course, Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap, the webinar centers on this crucial focus in cardiovascular disease prevention and risk assessment, as well as showcasing both current treatment for elevated lipoprotein(a) (Lp[a]) and new therapies on the horizon. Register here.
The ACC is currently accepting submissions of abstracts, complex clinical cases and interventional challenging cases to be presented at ACC.25, taking place March 29-31, 2025, in Chicago, IL. Submit your research for a chance to transform the future of cardiovascular care by sharing your research with over 12,000 attendees from more than 130 countries. The deadline for all submissions is 1 p.m. ET on Tuesday, Oct. 1. Don't miss your chance to be part of ACC.25 — submit your abstract or case today!
The ACC and Medscape have released an educational activity, Going Beyond Recognition: Treating Obesity as a Chronic Disease in Patients With or At Risk For Cardiovascular Disease, to help manage obesity through increased recognition and treatment. Led by Jorge Plutzky, MD, FACC, participants can earn up to 1 CME credit/MOC point and will increase their knowledge of the relationship between obesity and cardiovascular risk/cardiovascular disease, benefits of weight loss on cardiovascular health, and evidence-based treatment recommendations for obesity in patients with cardiovascular disease. View the activity.
Join prevention experts on Wednesday, Sept. 11 at noon ET for a recap of ACC.24 prevention content and its influence on our clinical practice. The webinar will review key highlights in lipidology, cardiometabolic disease, and hypertension from ACC.24 ...
The ACC and Medscape have released an educational activity, Obesity and Cardiology: Defining the Link and Examining Treatments, to help manage obesity through increased recognition and treatment. Moderated by Pamela B. Morris, MD, FACC, with expert faculty, A. Michael Lincoff, MD, FACC, and Jorge Plutzky, MD, FACC, participants can earn up to 0.75 CME credits/MOC points and will increase their knowledge of the relationship between obesity and cardiovascular risk/cardiovascular disease, benefits of weight loss on cardiovascular health, and evidence-based treatment recommendations for obesity in patients with cardiovascular disease. View the activity.
The elevation of lipoprotein(a) (Lp[a]) is a common risk factor responsible for considerable cardiovascular morbidity and mortality. To address this, the ACC has developed the Elevating Lp(a) Awareness: Bridging the CVD Risk Knowledge Gap online course. Learn about the unique role of Lp(a) as a genetic determinant for atherosclerotic cardiovascular disease risk and the importance of testing for Lp(a) levels to better understand your patients' cardiovascular health. Erin D. Michos, MD, FACC, outlines quick tips in the first video lesson, "Lipoprotein(a): Quick Take-Aways."
Cardiovascular disease is the leading cause of maternal mortality in the U.S. and maternal morbidity and mortality rates are rising. Cardio-Obstetrics Essentials, taking place Nov. 1-3 in Washington DC and virtually, provides the entire cardiovascular care team with the tools needed to get up to date on the evolving field of cardio-obstetrics. Register today to learn about the latest updates and join our efforts to improve maternal outcomes! Advanced registration ends Oct.1. Register now.
Hypertensive disorders of pregnancy affect about 8% to 10% of pregnant individuals. A new Postpartum Hypertension Clinic Development Toolkit – the result of an innovative collaboration that started between ACC's Pennsylvania Chapter and ACC's Reproductive Health and Cardio-Obstetrics Member Section thanks to a Chapter/Section grant – aims to increase awareness of hypertensive disorders of pregnancy and bridge gaps in care. Learn more.
Learning to correctly measure blood pressure is key to the diagnosis and management of hypertension. Failure to adhere to the correct techniques can lead to measurement errors of more than 30 mmHg. Understand the best practices for blood pressure measurement for hypertension patients with a new infographic, "Mismeasurement of Blood Pressure in the Office: Finding the Common Mistakes." Access the infographic, patient case quizzes and more free education in ACC's online course, Overcoming Challenges in Hypertension Management.
The ACC and Veradigm Inc. have announced a new "TRANSFORM VAX" initiative aimed at improving cardiovascular health through increased influenza vaccination education. Powered by Veradigm de-identified real-world data, TRANSFORM VAX will deliver educational messaging to health care providers whose patient cohorts meet ACC-determined criteria for inclusion. It will then compare results against a control group of physicians not receiving TRANSFORM VAX messaging, enabling the ACC to establish benchmarks from which to measure future quality improvement success. Learn more.
According to a recent State-of-the-Art Review published in JACC, poor diet has emerged as a top contributor to cardiovascular disease. "Food is Medicine" represents a spectrum of food-based interventions integrated into health care. Preliminary evidence suggests significant positive impacts of these programs, which include medically tailored meals, groceries and produce prescriptions for patients with specific health conditions and often social needs. Read more.
Submit your challenging rheumatic heart disease (RHD) cases highlighting the global burden of cardiovascular disease for a forthcoming special issue or mini-focus issue planned for fall or winter 2024. Topics range from pediatric acute RHD to primary prevention strategies, complex valvular heart disease and more. Submissions in any format are welcome and are due by Tuesday, April 30. Learn more.
Submit your challenging rheumatic heart disease (RHD) cases highlighting the global burden of cardiovascular disease for a forthcoming special issue or mini-focus issue planned for fall or winter 2024. Topics range from pediatric acute RHD to primary prevention strategies, complex valvular heart disease and more. Submissions in any format are welcome and should be made by Tuesday, April 30. Learn more.
Join your colleagues in Atlanta, April 6-8, for ACC.24 and explore the Prevention and Health Promotion Learning Pathway to get the core knowledge needed for this ever-expanding field, including biomarkers in risk prediction and emerging medical therapies for cardiometabolic disease and obesity. Through heated debates, thought-provoking case discussions, and the patient experience, experts will dive deep into several multidisciplinary topics, including the care of cardio-obstetrics patients and mitigating cardiometabolic risk in South Asians. Register by March 6 to SAVE and learn more about all ACC.24 has to offer!
Join ACC's Prevention of Cardiovascular Disease Section for a joint webinar with the American College of Clinical Pharmacy (ACCP) taking place Thursday, Jan. 18 at 3 p.m. ET.
Communities with historical health equity challenges are at the greatest risk for higher incidences of cardiovascular disease. Understanding the ways communities face challenges and live with heart disease and/or related risk factors is critical to developing sustainable community-based programs like ACC's Caring Hearts Initiative. As part of the program, the CardioSmart team has developed several resources on blood pressure, heart-healthy nutrition, active and mindful living. Download these resources for free here.
JACC: Heart Failure is inviting submissions for a special focus issue on strategies for the management of obesity and heart failure (HF).
The Patient-Centered Outcomes Research Institute (PCORI) is accepting Letters of Intent through Tuesday, Oct. 3 for patient-centered comparative clinical effectiveness research studies focused on broad strategies to reduce cardiovascular disease risk.
The prevalence of metabolic disorders, including obesity, metabolic syndrome, and type 2 diabetes (T2D), is escalating in Asian countries. Consequently, metabolic dysfunction leading to metabolic syndrome and T2D is expected to account for a majority of the health burden, including cardiovascular diseases, in these countries in the near future.
In a recent ACC CardiaCast podcast episode, Richard Josephson, MD, FACC, and Priyanka Satish, MD, discuss recent clarifications in Medicare regulations which facilitate physician billing and reimbursement for assessment and completion of the individualized treatment plan prior to a patient starting cardiac rehabilitation.
Join the ACC for a webinar on World Hypertension Day, May 17 at 7 p.m. ET.
Join Reproductive Health & Cardio-Obstetrics Section Co-Chairs Natalie Bello, MD, MPH, FACC, and Ki Park, MD, FACC, for the inaugural Section Meeting at ACC.23/WCC on Friday, March 3, from 6:30 to 8:30 p.m. CT at the Hilton Riverside, Kabakoff Room.
Join moderator Valentin Fuster, MD, PhD, MACC, and expert panelists Marianne Brodmann, MD; Christian Meyer, MD; Pablo Perel, MD, MSc, PhD; and Marco Valgimigli, MD, PhD, for an informative discussion on the regional trends and clinical implications of the burden of cardiovascular disease in Western Europe.
The world of cardiovascular prevention is exploding with respect to new therapies in lipidology, cardiometabolic disease and weight loss.
A new JACC webinar highlights regional considerations, geographic trends, and clinical implications of the burden of cardiovascular disease in Africa.
Learn contemporary approaches to the management of hypertension, the leading cause of cardiovascular disease, premature death, and disability-adjusted life years in the world with the ACC’s Overcoming Challenges in Hypertension Management online course.
The ACC and the National Heart, Lung, and Blood Institute will be partnering to host another Innovation Pitch Challenge March 4-5, 2023, at ACC.23/WCC in New Orleans.
The first Collaborative Maintenance Pathway (CMP) Performance Assessment window this year for CVD is taking place Oct 8-16. Delivered through ACCSAP, participants get access to all the comprehensive educational material and can stay 100% certified by focusing on just 20% of the field.
Familial hypercholesterolemia (FH) is the most common autosomal-dominant genetic disorder, affecting approximately 30 million patients worldwide. Earlier identification of any disease means earlier treatment and a greater potential to reduce or prevent untoward events.
Your high-risk cardiovascular patient has just become pregnant. What do you do now? Join us for a webinar, "A Team-Based Approach for When the Highest Risk Cardiovascular Patient Becomes Pregnant" for the guidance you need.
A new webinar based on the JACC special report, "Global Burden of Cardiovascular Diseases and Risk Factors," examines cardiovascular disease trends and modifiable risks in South America. Moderator Valentin Fuster, MD, PhD, MACC, is joined by panelists Edgardo Escobar, MD, FACC; Juan F. Granada, MD; Gláucia Maria Moraes de Oliveira, MD, MSc, PhD, FACC; and Daniel José Piñeiro, MD, FACC, in a discussion outlining on the most prevalent modifiable risk factors in the region, the implications of these findings on clinical practice, how clinicians can address modifiable risks with patients, and health policy considerations.
Improve your knowledge in the field of adult clinical cardiology with ACCSAP. This self-assessment program offers 190+ CME/MOC credits and includes comprehensive educational material available in three popular formats – text, video and self-assessment questions — and is updated yearly.
The Clinical Spotlight Series shines a light on best practices and emerging science across practice-changing topics in care including atrial fibrillation, lipid management and SGLT2 inhibitors in heart failure. Test your knowledge and earn up to 0.5 CME/MOC/CNE credits with two new certified patient cases as part of Modern Lipid Management: The Updated Medicine Cabinet.
August is National Immunization Awareness Month and this annual observance highlights the efforts of clinicians to protect patients of all ages against vaccine-preventable diseases through timely vaccination.
Learn contemporary approaches to the management of hypertension, the leading cause of cardiovascular disease, premature death, and disability-adjusted life years in the world with the ACC’s Overcoming Challenges in Hypertension Management online course.
A new webinar based on the JACC special report, "Global Burden of Cardiovascular Diseases and Risk Factors," examines cardiovascular disease trends and modifiable risks in North America.
When it comes to meeting maintenance of certification (MOC) requirements, you have choices! With the Collaborative Maintenance Pathway (CMP), there is no need to take a comprehensive exam covering the breadth of your field.
Familial hypercholesterolemia (FH) is the most common autosomal-dominant genetic disorder, affecting approximately 30 million patients worldwide and characterized by lifelong elevations in low-density lipoprotein cholesterol (LDL-C). Increase your familiarity with the new treatment options available to the cardiovascular community with the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment online course.
May is High Blood Pressure Education Month and May 17 is World Hypertension Day. High blood pressure—also known as hypertension—is a major risk factor for heart disease. As hypertension remains a challenge to control, innovative strategies to improve patient adherence play a crucial role in patient care.
In the May issue of Cardiology magazine, Seamus Whelton, MD, MPH; Joseph Ebinger, MD, MS, FACC; and Eugene Yang, MD, MS, FACC, offer a primer on caring for patients with hypertension, the leading cardiovascular disease risk factor.
Improve detection and diagnosis of familial hypercholesterolemia (FH) and increase familiarity with the new treatment options available to the cardiovascular community with the Familial Hypercholesterolemia: Improving Detection to Accelerate Treatment online course.
As hypertension remains a challenge to control, innovative strategies to improve patient adherence have a crucial role in patient care.
Black and Hispanic individuals who experience a witnessed cardiac arrest at home or in public are substantially less likely than White individuals to receive cardiopulmonary resuscitation (CPR) from a bystander, according to a study presented at ACC.22.
As hypertension remains a challenge to control, innovative and emerging treatment options will have an important role. Learn contemporary approaches to the management of hypertension, the leading cause of cardiovascular disease, premature death, and disability-adjusted life years in the world with the ACC's Overcoming Challenges in Hypertension Management online course.
Familial hypercholesterolemia (FH) is the most common autosomal-dominant genetic disorder, affecting approximately 30 million patients worldwide and characterized by lifelong elevations in low-density lipoprotein cholesterol (LDL-C).
How confident are you in the blood pressure readings you use in clinic? Interested in learning how to integrate home blood pressure monitoring into your clinical practice? Listen to the experts discuss these topics and more in the most recent CardiaCast episodes, brought to you by the ACC Prevention Section.
Learn about contemporary approaches to the management of hypertension – the leading cause of cardiovascular disease, premature death, and disability-adjusted life years in the world – with the ACC's Overcoming Challenges in Hypertension Management online course.
In the March issue of Cardiology magazine, Trevor Caldarera, MD, and Michael D. Shapiro, DO, MCR, FACC, write about the key drivers of atherosclerotic cardiovascular disease (ASCVD) risk and the need for better diagnosis and management of these residual risk factors to optimize prevention of ASCVD.
Now is the best time to take advantage of the Collaborative Maintenance Pathway (CMP) – an alternative option offered by the ACC and the American Board of Internal Medicine (ABIM) for meeting maintenance of certification (MOC) requirements, as well as all other education, licensure and certification needs.
Are you planning to submit an NCDR research proposal this year? Don’t miss the April 8 deadline! The NCDR Research & Publications (R&P) cycle offers one research proposal deadline annually for all NCDR programs except the STS/ACC TVT Registry.
Join global cardiovascular prevention experts, including Toshiki Kuno, MD, David Preiss, MD, ChB, PhD, and Neil J. Stone, MD, FACC, for an insider look at the evolving frontiers of prevention during the New York Cardiovascular Symposium, Dec. 11 – 12!
A new Patient Voices Video Series developed by CardioSmart features direct interviews and helpful tips from people living with high cholesterol.
The ACC has launched a new CardiaCast podcast series on nutrition, with new episodes dropping weekly.
The ACC Prevention of Cardiovascular Disease Section recently collaborated with the CardioNerds podcast for a discussion on ACC.21 prevention session highlights.
Improve your knowledge in the field of adult clinical cardiology with ACCSAP. This self-assessment program offers 160 CME/MOC credits and includes over 600 case-based practice questions, 130 modules of text and 50 video presentations from the ACC Cardiovascular Overview and Board Prep course.
In the latest issue of JACC: Case Reports, Shirlene Obuobi, MD, Danielle Belardo, MD, and Martha Gulati, MD, MS, FACC, discuss the effect of social determinants of health on atherosclerotic cardiovascular disease prevention.
The inaugural issue of JACC: Asia is now live. JACC: Asia is the first region-specific cardiovascular journal with original peer-reviewed content, featuring state-of-the-art reviews, original research papers, editorial comments and research letters by Asian authors and focused on Asian patient populations.
The ACC has collaborated with Medscape to create the Cardiovascular Risk Reduction Center of Excellence.
Have thoughts about the Late Breaking Clinical Trials and Hot Topics? We want to hear them!
Don’t miss the April 9 deadline to submit an NCDR research proposal in 2021! Last year, NCDR changed its Research & Publications (R&P) cycle to offer one research proposal deadline annually, with one annual review meeting for all NCDR programs except the STS/ACC TVT Registry.
Are you planning to submit an NCDR research proposal this year? Don’t miss the April 9 deadline!
Improve your understanding of the influenza vaccines and their impact on cardiovascular patients with the “Taking the Lead: Flu and Cardiovascular Disease” hub.
The ACC Prevention Clinical Topic Collection continues to provide educational content on topics imperative to all health care professionals related to cardiovascular disease prevention.
Cardiovascular disease is the leading cause of death among American Indians and Alaska Natives, which is not surprising given that it is also the leading cause of death in the U.S.
Creating individualized management and prevention strategies for people with Type 2 diabetes has become increasingly complex, especially when physicians have to navigate new clinical guidelines, pathways and novel therapy choices.
Join the ACC in recognizing National Cholesterol Education Month. ACC's Guideline on the Management of Blood Cholesterol Hub provides a breakdown of the 2018 guidelines, CME, CE and MOC education activities, apps and tools, commentary, and patient resources.
In the first installment of a new video series, JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, is joined by Associate Editor Ron Witteles, MD, FACC; Wilson Gonsalves, MD; and Rola Khedraki, MD, for two insightful, informative 30-minute discussions on the topic of Amyloidosis.
Explore the unique risk factors for cardiovascular disease in women – as well as prevention and treatment strategies – when you register for an ACC live webinar on June 18.
Submit your abstract for ACC Quality Summit, scheduled for Oct. 7 – Oct. 9 in Orlando, FL.
The ACC is seeking comments on a draft of the 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or with Atherosclerotic Cardiovascular Disease.
Surround yourself with colleagues who understand the challenges and opportunities you face in your daily practice. Don't miss the Prevention Section Meeting and Reception, taking place March 29 at 5:30 p.m. CT at the Marriott Marquis Chicago, at ACC.20/Together With World Congress of Cardiology.
JACC: Heart Failure is seeking submissions for a themed issue highlighting cardiogenic shock to publish this November. The issue will examine the evolution of new therapies and novel treatment approaches for cardiogenic shock.
Cardiovascular disease is estimated to be present in 1-3 percent of pregnancies, and the incidence is increasing. As a cardiologist who has a special interest in pregnant women with cardiovascular disease, and as a mother of twins, Colleen Harrington, MD, FACC, is challenged academically and emotionally in treating these patients.
A new viewpoint published in JACC: Case Reports highlights the value of OB-GYN history in screening for cardiovascular risk factors in women and stresses the importance of developing a system to transition women – such as those with hypertensive disorders during pregnancy – to regular follow-up with a primary care physician or cardiologist.
Over the past few years, the medical community has seen an increasing number of trials emerging for SGLT2 inhibitors and GLP-1 receptor agonist agents demonstrating positive results in reducing the risk for patients with cardiovascular disease and diabetes. Stay up to date with ACC's new webpage, Cardiovascular Risk in Diabetes: Applying Emerging Science to Practice.
The highly anticipated second issue of JACC: CardioOncology features an impressive lineup of original research, reviews and case challenges on topics such as hypertension in cancer patients and survivors, ATTR amyloid, ischemia and bleeding in cancer patients undergoing PCI, cardiovascular prevention strategies in breast cancer and more.
The ACC hosted its first patient forum focused on diabetes and heart disease, Living Well With Type 2 Diabetes and Cardiovascular Disease, on Oct. 30 at ACC's Heart House.
The ACC offers numerous tools and resources on diabetes prevention and management for clinicians and patients for Diabetes Awareness Month.
There are a lot of big ways to get involved with the College – being on a Section Leadership Council, participating on a taskforce or committee, or serving as faculty for a live course, to name a few. However, we know that not everyone has the time for some of these larger-scale commitments. That's why the ACC is excited to announce the launch of our Microvolunteering Platform.
Applications are now being accepted for the ACC Leadership Academy Cohort IV, which will launch at ACC.20/World Congress of Cardiology in Chicago, IL.
Join world-renowned cardiologist and course director Valentin Fuster, MD, PhD, MACC, at ACC's New York Cardiovascular Symposium, taking place Dec. 6 – 8.
Join the ACC in recognizing National Cholesterol Education Month. ACC's Guideline on the Management of Blood Cholesterol Hub provides a breakdown of the 2018 guidelines, CME, CE and MOC education activities, apps and tools, commentary, and patient resources.
While healthy habits are important steps to prevent heart disease, it is also important to keep an eye on factors that make heart disease more likely, including diabetes, high blood pressure and high cholesterol.
The incremental understanding of cardiovascular disease over the past three decades has led to advances in its risk factor modifications and treatment strategies. Therefore, newer guidelines on prevention and treatment measures related to lipids, hypertension, diabetes, obesity, thrombosis and vascular diseases have exponentially increased.
Cardiology is the ACC's flagship member magazine — your member magazine — providing cardiovascular professionals with a comprehensive source for clinical and professional news. Find links to all of the July issue's articles and share on social media!
Check out the ACC.19 Meeting Coverage Page for post-meeting content to reinforce the teaching points and education presented during ACC.19.
As concerns about the addictive nature of e-cigarettes increase, it is important to bring awareness to risks of vaping.
CardioSmart's cholesterol condition center helps patients learn more about high cholesterol; treatment options such as statins, PCSK9 inhibitors and heart-healthy living tips; and the 2018 Cholesterol Guideline.
The ACC has made a select number of travel awards available to cover expenses for members to travel to ACC's 2019 Legislative Conference, Nov. 3 – 5, in Washington, DC.
The ACC.19 Meeting Coverage Page on ACC.org now features post-meeting content on dyslipidemia to reinforce the teaching points and education presented during ACC.19.
June is Men's Health Month and ACC's CardioSmart team is celebrating Men's Health Week from June 10 – 16.
The CardioSmart team's new one-page handout (double-sided) provides patients with important facts about heart disease prevention and helps patients track their heart-healthy habits.
In a new Leadership Page published in the Journal of the American College of Cardiology, ACC President Richard J. Kovacs, MD, FACC, reflects on ACC.19; the new Primary Prevention Guideline; and his mother, Elizabeth M. Kovacs, who passed away in 2018 at the age of 99.
Heart disease, stroke and diabetes are not only caused and exacerbated by high blood pressure and high cholesterol but also poor lifestyle behaviors including an unhealthy diet.
As we mark National Physical Fitness and Sports Month, Cardiology magazine featured photos of activities that members enjoy in their pursuit of being fit.
A special issue of the Journal of the American College of Cardiology, published April 22 on cardiovascular health promotion, covers topics such as healthy behaviors in preschoolers, the importance of eating breakfast, plant-based dietary patters and incident heart failure, sitting time and risk of death, survival among SIHD patients with diabetes, benefits of omega-3 fatty acid supplementation, and more.
The new ACC and American Heart Association (AHA) primary prevention guideline provides a comprehensive roadmap of strategies that can be used and tailored to help prevent or slow the development of atherosclerotic cardiovascular disease.
In a new video interview, Brendan Everett, MD, FACC, and James L. Januzzi Jr., MD, FACC, discuss key points to remember from the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.
Get a unique perspective on ACC.19 by following this year's Learning Pathway Tweeters.
ACC's Cardiovascular Health Promotion course, taking place May 30 – June 1 in Washington, DC, provides the latest in evidence-based practice for cardiovascular health promotion and disease prevention, as well as practical strategies for lifestyle medicine for the cardiac care team.
Join the ACC in recognizing Cardiac Rehab Awareness Week from Feb. 10 – 16 as part of American Heart Month.
Join us at the ACC.19 All-Section Reception, March 17, from 6:30 p.m. – 8 p.m., at the Hilton New Orleans Riverside, Grand Ballroom A.
The highly anticipated Primary Prevention Guideline will be released on Sunday, March 17 at 2 p.m. CT, during ACC.19.
Take advantage of free, online certified educational activities to fulfill your 2018 CME requirements and earn MOC credit at the same time!
The ACC Prevention of Cardiovascular Disease Section and Cardiac Rehabilitation Work Group created a series of free webinars aimed at optimizing care for cardiac rehab patients.
The fifth in a series of patient case quizzes, The Very High Risk Patient With Diabetes, tests your knowledge of cardiovascular risk and diabetes.
In the latest issues of Cardiology, deep-dive into the emerging risk factors of gestational hypertension and preeclampsia.
The ACC's new 2018 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease addresses the changing paradigm in how cardiovascular specialists should approach care of type 2 diabetes (T2D) patients.
In this deep-dive video discussion, Valentin Fuster, MD, PhD, MACC; Deepak L. Bhatt, MD, MPH, FACC; Anne B. Curtis, MD, FACC; Peter Libby, MD, FACC; and Marc Ruel, MD, MPH, share their perspectives on the most significant science released during AHA.18.
While continued improvement in medical and device therapy for heart failure has led to better survival rates, there may be stronger evidence that heart failure can be prevented by favorable lifestyle choices vs. treatment of existing heart failure, according to a perspective from ACC's Prevention of Cardiovascular Disease Council published Oct. 29 in the Journal of the American College of Cardiology.
Enhance your knowledge and earn credit with several of ACC’s Certified Patient Cases focused on prevention.
The overall goal of this activity is to provide physicians with the knowledge they need to better utilize Cardiac Rehab, by serving as a source of information that is not readily available. This five-part webinar series was created by the ACC Prevention of Cardiovascular Disease Council.
An innovative eight-part Cardiovascular Health Promotion Series published in the Journal of the American College of Cardiology (JACC) provides health care professionals with an in-depth examination of the eight risk factors and behaviors that contribute most to cardiovascular disease development.
The September 2018 issue of Cardiology, YOUR member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
ACC.19 registration is NOW OPEN exclusively for ACC members. Nonmember registration will open Wednesday, Sept. 26. Register early for the lowest rates and best selection of hotel rooms!
A series of eight state-of-the-art reviews is now publishing in the Journal of the American College of Cardiology (JACC). One review is publishing each week, examining the top risk factors affecting the cardiovascular health of patients: diet, tobacco, lipid control/cholesterol, blood pressure, psychological health, weight, physical activity and blood sugar.
On Valentine’s Day 1994, I was 5 years old and carefully crafting a card for my grandparents in art class. I remember gluing a white lace heart onto a red sheet of construction paper, excited to share my masterpiece. My grandfather picked me up from the bus stop that afternoon. Once home, he held his chest and reported pain. He tragically died in route to the hospital from a massive myocardial infarction at the age of 61. While I cannot recall if my grandfather’s early death was the impetus for my longstanding aspiration to become a cardiologist, it undoubtedly influenced my interest in preventive cardiology.
The effectiveness of sodium-glucose co-transporter 2 inhibitors (SGLT2i) highlights the importance of well-powered clinical trials that have identified a new treatment strategy for type 2 diabetes, according to a state-of-the-art review published July 31 in the Journal of the American College of Cardiology.
Save the date for the next ACC Twitter Journal Club on Wednesday, Sept. 12, 3 - 4 p.m. ET! ACC Journal Club faculty members Dipti Itchhaporia, MD, FACC, and John Ryan, MD, FACC. Itchhaporia AND Ryan will be joined by Annabelle Volgman, MD, FACC, ACC Cardiovascular Disease in Women committee member; Andrew Freeman, MD, FACC, ACC Prevention of Cardiovascular Disease Section council member; and Dave Dixon, PharmD, FACC, ACC Diabetes and Cardiometabolic Disorder sub-section member, to discuss some of the hottest topics from ESC Congress 2018 in Munich.
The August 2018 issue of Cardiology, YOUR member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The ACC.18 Meeting Coverage Page on ACC.org features post-meeting content from the Prevention Learning Pathway to reinforce the teaching points and education presented during ACC.18.
A draft of the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes is open for comment until July 5.
A special issue of the Journal of the American College of Cardiology, published May 28, focuses on the promotion of cardiovascular health, including issues that broadly impact public health and the prevention of cardiovascular disease and related conditions.
A new online ACC hub focused on “Lifting the Burden of Cardiovascular Disease and Diabetes” provides a host of free, education activities designed to help cardiovascular care professionals close the gap in new cardiometabolic pharmacotherapy.
The ACC.18 Meeting Coverage Page on ACC.org features post-meeting content from the Prevention Learning Pathway to reinforce the teaching points and education presented during ACC.18.
The ACC.18 Meeting Coverage Page on ACC.org now features post-meeting content that is meant to reinforce the teaching points and education presented during ACC.18 from the Prevention Learning Pathway.
The College’s Diabetes Collaborative Registry is seeking research proposals and has extended its research proposal application (RPA) deadline to Friday, June 1. Launched in 2014, the Diabetes Collaborative Registry has become a powerful resource for studies on the care and management of diabetic patients across multiple clinical specialties in the ambulatory space.
Cardiovascular disease remains the leading cause of death in America, with well-established and identifiable risk factors. Modifiable risk factors are the primary driver for first cardiovascular event, and risk factor modification has been a significant driver for reduction of cardiovascular death in certain populations in recent decades.
Join the ACC in recognizing Cardiac Rehab Awareness Week from Feb. 11 – 17 as part of American Heart Month. Clinicians can easily explain the benefits of cardiac rehab with CardioSmart's Cardiac Rehab infographic.
The latest issue of Cardiology reviews new information found this year in the prevention of cardiovascular disease, including the most recent piece of information that lower blood pressure and earlier treatment brings benefit.
In the latest ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, is joined by Deepak L. Bhatt, MD, MPH, FACC; Rachel J. Lampert, MD, FACC; Prediman K. Shah, MD, MACC; and Chadwick W. Stouffer, MD, in a roundtable discussion of the hottest trials from AHA 2017 in Anaheim, CA. Among the trials discussed are DACAB, CANVAS, EXSCEL, POISE-2 and more.
The ACC, along with the American Heart Association and the Heart Rhythm Society, have published new guidelines for the treatment of adult patients with ventricular arrhythmias (VA) or who are at risk for sudden cardiac death. The new guidelines replace the 2006 ACC/AHA/SC Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death and provide recommendations regarding general evaluation of patients with documented or suspected VA; treatments, therapies and prevention of VA; acute management of specific VA; and VA in the structurally normal heart.
The National Quality Forum’s Cardiovascular Standing Committee is accepting applications for its upcoming measure review cycle to evaluate new and previously endorsed performance measures for heart disease.
In conjunction with the ACC Committee Nominations cycle, the College’s Membership Committee is now accepting applications through Sept. 22. The Membership Committee was established as part of the 2015 College’s governance transformation and serves as standing committee of the College, reporting directly to the Board of Trustees.
As a result of recent evidence regarding proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors and ezetimibe in some patients, the ACC has released the 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk, which published Sept. 5 in the Journal of the American College of Cardiology.
Watch the new "ACC Cardiology Hour," an expert roundtable discussion of the hottest trials from ESC Congress 2017.
The August 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The ACC/American Heart Association (AHA) Task Force on Performance Measures is accepting public comments on the draft of the 2018 ACC/AHA Cardiac Rehabilitation Performance Measure Set, including any measures that the committee should consider modifying, removing or adding.
Plant-based diets are recommended to reduce the risk of heart disease, but some may be associated with a higher risk, according to a study published July 17 in the Journal of the American College of Cardiology.
The July 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
The ACC is seeking qualified candidates to serve as vice chair of the Annual Scientific Session for a two-year term of office for ACC.19 and ACC.20, moving on to assume another two-year term as chair of ACC.21 and ACC.22.
The ACC.org editors have created additional prevention-related content meant to reinforce the teaching points and education presented during ACC.17.
Cardiovascular disease (CVD), including heart diseases and stroke, account for one-third of deaths throughout the world, according to a study recently published in the Journal of the American College of Cardiology (JACC) that examined every country over the past 25 years.
The ACC.org editors have created additional prevention-related content meant to reinforce the teaching points and education presented during ACC.17.
The June 2017 issue of Cardiology, ACC’s flagship member magazine, is now live! Cardiology provides cardiovascular professionals with comprehensive clinical, professional and health policy news; feature-length articles on the top trends and innovations in cardiovascular medicine; expert commentary from leaders in the cardiovascular field; quick-read summaries of the latest research from the JACC Journals and other major cardiovascular journals; profiles of ACC members, like you; and so much more!
Learn about the latest in cardiovascular nutrition, including recommendations from the USDA, the danger about TMAO from your gut flora, how emotions can effect CV disease, why cholesterol in the diet matters, and how reversing CAD with diet is achievable.
The ACC.org editors have created additional prevention-related content meant to reinforce the teaching points and education presented during ACC.17.
ACC’s CardioSmart team has created a new Women & Heart Disease infographic to help women stand up for their heart health.
Preventive medicine along with lifestyle modification (including adopting and/or adhering to a heart healthy diet, regular exercise habits, avoidance of tobacco products, and achieving or maintaining a healthy weight) remains the foundation for health promotion and cardiovascular disease risk reduction. However, most Americans continue to lead an unhealthy lifestyle and fewer than 1 percent of adults have all seven AHA cardiovascular health metrics at ideal levels.
Watch the new ACC Cardiology Hour, an expert roundtable discussion of late-breaking clinical trials from ACC.17.
Cardiologists are treating more and more patients with established cardiovascular disease and diabetes. Over the last decade, studies have shown that patients with diabetes are at greater risk of dying from cardiovascular disease than those without diabetes.
Attending ACC.17? Join us for the All-Section Meeting & Reception at ACC.17! The event happening THIS Saturday, March 18, 2017 from 6:00 p.m. – 7:30 p.m. at the Marriott Marquis will give you a chance to learn more about what ACC's 19+ Member Sections are working to accomplish and to connect with members in your specialty or interest areas.
Only at ACC.17 will you have the opportunity to learn everything you need to address the evolving world of cardiovascular medicine and achieve success in your profession. Mark your calendar for the All-Sections Meeting and Reception on Saturday, March 18 from 6:00 – 7:30 p.m. at the Marriott Marquis. Additional sessions on prevention will also be offered. Click for more information.
A special issue of the Journal of the American College of Cardiology (JACC), published Feb. 27, focuses on the promotion of cardiovascular health, including topics such as dietary habits, antioxidant pills and physical activity – and the prevention of cardiovascular disease and other related conditions.
Save the Date for the All-Section Meeting & Reception at ACC.17! Happening on Saturday, March 18, 2017 from 6:00 p.m. – 7:30 p.m. at the Marriott Marquis, this event will give you a chance to learn more about what ACC’s 19+ Member Sections. Submit your RSVP to attend.
Analysis exploring Medicare formulary changes following the publication of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults found that, although the cholesterol guideline was originally associated with more restrictive formulary coverage of non-statin lipid-lowering medications, many formularies continue to provide unrestrictive coverage.
A new risk assessment tool, funded by the Centers for Medicare and Medicaid Services (CMS) in partnership with the ACC and the American Heart Association (AHA), may help to better predict the 10-year risk of developing atherosclerotic cardiovascular disease (ASVCD) and how that risk may change over time as preventive treatments are initiated.
Join a panel of speakers on Monday, Dec. 12 at 8:00 p.m. ET to hear about preventive medicine along with lifestyle modification, including adopting and/or adhering to a heart healthy diet, regular exercise habits, avoidance of tobacco products, and achieving or maintaining a healthy weight.
The Summer 2016 issue of Cardiology magazine includes a feature article on Paul L. Douglass, MD, MACC, who received the Master of the ACC (MACC) designation at ACC.16 in Chicago. Douglass was an “As an early voice for the issue of health care disparities in...
The Spring issue of Cardiology magazine examines the pending legislation before the U.S. Congress that would expand access to cardiac rehabilitation (rehab) for patients in areas of need and to transform secondary prevention of cardiovascular disease across the country.
Encourage patients to register for a new webinar focusing on hypertension on May 17 at 12 p.m. ET from ACC’s CardioSmart Heart Forum. Keith Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine, will provide a general overview on hypertension...
The ACC/AHA Task Force on Performance Measures has developed a prevention of sudden cardiac death measure set. The Task Force is seeking public comments on the measure set. Before completing the survey, please review the draft prevention of sudden cardiac measure set.
In a recent post on the ACC in Touch Blog, Richard A. Josephson, MS, MD, FACC, and Derin Tugal, MD, discuss the challenges of enrolling cardiovascular disease patients cardiac rehabilitation (rehab)and resources to encourage participation. “Despite numerous publications and international guidelines in support of cardiac rehab for patients … implementation of cardiac rehab remains suboptimal.
Help patients learn how to be more physically active and in tune with their stress levels with CardioSmart’s Active and Mindful Living Infographic – available for download now.
Cardiology recently sat down with Pamela Bowe Morris, MD, FACC, to discuss her career path in cardiology and her thoughts on the future of population health. She is currently the director of preventive cardiology, co-director of Women’s Heart Care, and an assistant professor of medicine at the Medical University of South Carolina.
In a recent certified Expert Analysis, Samuel S. Gidding, MD, FACC, Patrick M. Moriarty, MD, FACC, and Geetha Raghuveer, MD, MPH, discuss homozygous familial hypercholesterolemia (FH), with a goal to improve clinical competency in the evaluation, diagnosis and management of patients with FH.
“She came to me with severe muscle aches and very high cholesterol, hoping I could treat her,” remembers Alan Brown, MD, FACC, a member of the College’s Prevention of Cardiovascular Disease Section, and a specialist in preventative medicine. “So I ran some tests, asked for a patient history and discovered she had Familial Hypercholesterolemia (FH), an inherited disease caused by a mutation in the low-density-lipoprotein (LDL) receptor gene.”
Clinical pharmacists play an important role for patients on the cardiovascular care team, according to a joint Council Perspective from the Cardiovascular Team Section and Prevention of Cardiovascular Disease Section published Nov. 2 in the Journal of the American College of Cardiology. The authors note that as a result of advanced training, clinical pharmacists have been associated with decreased costs of care, hospital mortality, drug costs, length of stay and medication error rates.
While advancements have been made in the field of tobacco-related research, smoking cessation rates have slowed in recent years, showing that there is still need for greater understanding of the cardiovascular effects of cigarette smoke exposure and electronic cigarettes, according to a council perspective from ACC’s Prevention of Cardiovascular Disease Section Leadership Council and Early Career Council published Sept. 14 in the Journal of the American College of Cardiology.
The ACC has endorsed Million Hearts’ new Cardiovascular Risk Reduction Model – the first of its kind from the Centers for Medicare and Medicaid Services. The model is structured as a randomized trial made up of Medicare Fee for Service beneficiaries from 360 control and 360 intervention practices, combining for roughly 150,000 subjects in each arm.
Although the U.S. Centers for Medicare Services has extended cardiac rehabilitation (rehab) coverage to patients with heart failure with reduced ejection fraction (HFrEF), enrolling these patients in cardiac rehab may prove difficult, according to a Council Perspective published June 15 in the Journal of the American College of Cardiology.
There was no change in overall tobacco use in middle and high school students between 2011 and 2014, according to the results of the 2014 National Youth Tobacco Survey; however, the use of hookah and e-cigarettes went up significantly.
The ACC’s CardioSmart program has developed a series of patient-focused infographics designed to provide informative and vibrant visual summaries of cardiovascular and lifestyle topics ranging from active living to heart valve disease.
Million Hearts® released a new Cardiovascular Risk Reduction Model that offers a novel way of lowering risks of heart attack and stroke by proposing a new way to pay for prevention. Using a data-driven, predictive modelling approach, the Million Hearts model will generate an individualized 10-year risk score for each participant. With access to this information, providers and patients can work together to explore various solutions.
As we battle the obesity epidemic it has been increasingly important to not only advise heart healthy eating habits, but to emphasize the necessity for regular aerobic activity, writes Deirdre J. Mattina, MD, of Henry Ford Hospital, Detroit, MI, and member of the Prevention of Cardiovascular Disease Section Leadership Council, in an ACC in Touch Blog.
